Common Stock, Shares, Outstanding of Inhibikase Therapeutics, Inc. from Q4 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Inhibikase Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and change rate from Q4 2020 to Q3 2025.
  • Inhibikase Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2025 was 74.8M shares, a 902% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Inhibikase Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 74.8M +67.3M +902% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 74.5M +67.3M +933% Jun 30, 2025 10-Q 2025-08-14
Q1 2025 74.3M +67.9M +1048% Mar 31, 2025 10-Q 2025-05-14
Q4 2024 69.4M +63.2M +1021% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 7.46M +2.1M +39.2% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 7.22M +1.93M +36.4% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 6.48M -24.6M -79.1% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 6.19M +1.96M +46.4% Dec 31, 2023 10-K 2025-03-27
Q3 2023 5.36M -19.9M -78.8% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 5.29M -19.9M -79% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 31.1M +5.83M +23.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 4.22M -20.9M -83.2% Dec 31, 2022 10-K 2024-03-27
Q3 2022 25.2M +71.9K +0.29% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 25.2M +93.7K +0.37% Jun 30, 2022 10-Q 2022-08-12
Q1 2022 25.2M +15.2M +151% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 25.2M +15.1M +150% Dec 31, 2021 10-K 2023-03-31
Q3 2021 25.2M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 25.1M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 10.1M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 10.1M Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.